Results 11 to 20 of about 30,879 (201)

Reference values for lung function tests: III. Carbon monoxide diffusing capacity (transfer factor) [PDF]

Brazilian Journal of Medical and Biological Research, 1999
Carbon monoxide diffusing capacity (DLCO) or transfer factor (TLCO) is a particularly useful test of the appropriateness of gas exchange across the lung alveolocapillary membrane. With the purpose of establishing predictive equations for DLCO using a non-
Neder J.A., Andreoni S., Peres C., Nery L.E.   +3 more
doaj   +3 more sources

Author Correction: Pulmonary diffusing capacity among individuals recovering from mild to moderate COVID-19: a cross-sectional study. [PDF]

Sci Rep
Yelin D, Ghantous N, Awwad M, Daitch V, Kalfon T, Mor M, Buchrits S, Shafir Y, Shapira-Lichter I, Leibovici L, Yahav D, Margalit I, Shitenberg D.   +12 more
europepmc   +3 more sources

Hypoxic Pulmonary Vasoconstriction and the Diffusing Capacity in Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Seiichiro Sakao, Nobuhiro Tanabe, Koichiro Tatsumi   +2 more
doaj   +2 more sources

Simultaneous Measurement of Lung Diffusing Capacity and Pulmonary Hemodynamics Reveals Exertional Alveolar‐Capillary Dysfunction in Heart Failure With Preserved Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Hemodynamic perturbations in heart failure with preserved ejection fraction (HFpEF) may alter the distribution of blood in the lungs, impair gas transfer from the alveoli into the pulmonary capillaries, and reduce lung diffusing capacity.
Caitlin C. Fermoyle, Glenn M. Stewart, Barry A. Borlaug, Bruce D. Johnson   +3 more
doaj   +1 more source

Lymphangioleiomyomatosis: circulating levels of FGF23 and pulmonary diffusion [PDF]

Jornal Brasileiro de Pneumologia, 2023
Objective: Lymphangioleiomyomatosis (LAM) is a rare, destructive disease of the lungs with a limited number of determinants of disease activity, which are a critical need for clinical trials.
Anthony J Esposito, Jewel Imani, Shikshya Shrestha, Shefali Bagwe, Anthony M Lamattina, Marina Vivero, Hilary J Goldberg, Ivan O Rosas, Elizabeth P Henske, Souheil Y El-Chemaly   +9 more
doaj   +1 more source

Pseudoxanthoma Elasticum - Also a Lung Disease? The Respiratory Affection of Patients with Pseudoxanthoma Elasticum. [PDF]

PLoS ONE, 2016
BACKGROUND:Pseudoxanthoma elasticum (PXE) is an autosomal-recessive mineralisation disorder caused by loss of function mutations in the ABCC6 Gen. Histological findings and data of an autopsy of a PXE-patient suggest a possible pulmonal calcification. So
Simon Pingel, Sebastian Gorgonius Passon, Kristin Solveig Pausewang, Anna Katharina Blatzheim, Carmen Pizarro, Izabela Tuleta, Martin Gliem, Peter Charbel Issa, Nadjib Schahab, Georg Nickenig, Dirk Skowasch, Christian Alexander Schaefer   +11 more
doaj   +1 more source

Alveolar-membrane diffusing capacity limits performance in Boston marathon qualifiers. [PDF]

PLoS ONE, 2012
PURPOSE: (1) to examine the relation between pulmonary diffusing capacity and marathon finishing time, and (2), to evaluate the accuracy of pulmonary diffusing capacity for nitric oxide (DLNO) in predicting marathon finishing time relative to that of ...
Kaleen M Lavin, Allison M Straub, Kathleen A Uhranowsky, James M Smoliga, Gerald S Zavorsky   +4 more
doaj   +1 more source

Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controls

Frontiers in Physiology, 2022
Background: Up to 53% of individuals who had mild COVID-19 experience symptoms for >3-month following infection (Long-CoV). Dyspnea is reported in 60% of Long-CoV cases and may be secondary to impaired exercise capacity (VO2peak) as a result of ...
Rhys I. Beaudry, Andrew R. Brotto, Rhea A. Varughese, Stephanie de Waal, Desi P. Fuhr, Ronald W. Damant, Giovanni Ferrara, Grace Y. Lam, Maeve P. Smith, Michael K. Stickland, Michael K. Stickland   +10 more
doaj   +1 more source

Inflammation associated with lung function abnormalities in COVID-19 survivors

BMC Pulmonary Medicine, 2023
Background Activation of inflammatory pathways promotes organ dysfunction in COVID-19. Currently, there are reports describing lung function abnormalities in COVID-19 survivors; however, the biological mechanisms remain unknown. The aim of this study was
Roberto Mancilla-Ceballos, Kathryn M. Milne, Jordan A. Guenette, Arturo Cortes-Telles   +3 more
doaj   +1 more source

Epigenome-wide association study on diffusing capacity of the lung

ERJ Open Research, 2021
Background Epigenetics may play an important role in the pathogenesis of lung diseases. However, little is known about the epigenetic factors that influence impaired gas exchange at the lung.
Natalie Terzikhan, Hanfei Xu, Ahmed Edris, Ken R. Bracke, Fien M. Verhamme, Bruno H.C. Stricker, Josée Dupuis, Lies Lahousse, George T. O'Connor, Guy G. Brusselle   +9 more
doaj   +1 more source